ArticleInvestigational new drugs2016

Determination of unbound fraction of pazopanib in vitro and in cancer patients reveals albumin as the main binding site.

Diane-Charlotte Imbs et al.PubMed ↗Publisher ↗

No numbers read from the abstract.